Haemonetics Corporation HAE
$ 85.65
0.97%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
1991 |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
CEO |
Mr. Christopher Simon |
Employees in the company |
3 004 |
Shares |
50.7 M |
Market Cap[1] |
$ 4.34 B |
EBITDA (LTM) |
$ 245 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.